Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Periventricular microglial cells interact with dividing precursor cells in the nonhuman primate and rodent prenatal cerebral cortex.

The Journal of comparative neurology | 2019

Cortical proliferative zones have been studied for over 100 years, yet recent data have revealed that microglial cells constitute a sizeable proportion of ventricular zone cells during late stages of cortical neurogenesis. Microglia begin colonizing the forebrain after neural tube closure and during later stages of neurogenesis populate regions of the developing cortex that include the proliferative zones. We previously showed that microglia regulate the production of cortical cells by phagocytosing neural precursor cells (NPCs), but how microglia interact with NPCs remains poorly understood. Here we report on a distinct subset of microglial cells, which we term periventricular microglia, that are located near the lateral ventricle in the prenatal neocortex. Periventricular microglia exhibit a set of similar characteristics in embryonic rat and fetal rhesus monkey cortex. In both species, these cells occupy ~60 μm of the ventricular zone in the tangential axis and make contact with the soma and processes of NPCs dividing at the ventricle for over 50 μm along the radial axis. Periventricular microglia exhibit notable differences across species, including distinct morphological features such as terminal bouton-like structures that contact mitotic NPCs in the fetal rhesus monkey but not in rat. These morphological distinctions suggest differential functions of periventricular microglia in rat and rhesus monkey, yet are consistent with the concept that microglia regulate NPC function in the developing cerebral cortex of mammalian species.

Pubmed ID: 30552670 RIS Download

Associated grants

  • Agency: NIH HHS, United States
    Id: S10 OD016261
  • Agency: NIH HHS, United States
    Id: P51 OD011107
  • Agency: NICHD NIH HHS, United States
    Id: U54 HD079125
  • Agency: NHLBI NIH HHS, United States
    Id: R24 HL085794
  • Agency: NIH HHS, United States
    Id: S10 OD018102
  • Agency: NIMH NIH HHS, United States
    Id: R01 MH101188

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Iba1 antibody (antibody)

RRID:AB_2224402

This polyclonal targets AIF1

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

phospho-vimentin (Ser55) : Trial Size (antibody)

RRID:AB_592962

This monoclonal targets phospho-vimentin (Ser55) : Trial Size

View all literature mentions

Iba1 antibody (antibody)

RRID:AB_2224402

This polyclonal targets AIF1

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

phospho-vimentin (Ser55) : Trial Size (antibody)

RRID:AB_592962

This monoclonal targets phospho-vimentin (Ser55) : Trial Size

View all literature mentions

phospho-vimentin (Ser55) : Trial Size (antibody)

RRID:AB_592962

This monoclonal targets phospho-vimentin (Ser55) : Trial Size

View all literature mentions

Iba1 antibody (antibody)

RRID:AB_2224402

This polyclonal targets AIF1

View all literature mentions

Anti Iba1, Rabbit antibody (antibody)

RRID:AB_839504

This polyclonal targets Iba1

View all literature mentions

phospho-vimentin (Ser55) : Trial Size (antibody)

RRID:AB_592962

This monoclonal targets phospho-vimentin (Ser55) : Trial Size

View all literature mentions